Product logins

Find logins to all Clarivate products below.


Neurostimulation Devices – Market Insights – Europe (Supplemental)

The European neurostimulation market will grow modestly through 2033. Growth in this market is largely driven by product innovations, particularly in the SCS and DBS segments, and iterative improvements introduced by competitors in various market segments. However, competition from noninvasive technologies, strict patient selection criteria, and limited reimbursement will limit market growth to some extent.

This Medtech 360 Report provides high-level market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Neurostimulation Devices – Market Insights – United States
The US neurostimulation device market will be driven by strategic acquisitions, rapid adoption of novel technologies and increasing availability of advanced products, and new approvals and device…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…